Scholar Rock Holding Corp Sustainability Reports
Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases. The company leverages its proprietary platform to design antibodies that target protein growth factors in their latent forms to treat neuromuscular diseases, cardiometabolic disorders, and cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z1FLPGL4OWJ459
FIGI: BBG00KT2RSD4
1 reports from 2021 to 2021